ALMOOSA

Almoosa Health Co.

4018StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	210.70M	183.68M	40.07M	-10.97M	197.72M
Free Cash Flow	210.70M	-56.66M	-343.12M	-318.15M	-120.76M
Capital Expenditures	—	-240.34M	-383.19M	-307.18M	-318.47M
Investing & Financing
Investing Cash Flow	-646.90M	-262.23M	-454.39M	-310.04M	-315.49M
Financing Cash Flow	436.30M	100.92M	414.92M	278.13M	125.71M
Dividends Paid	—	-14.01M	—	—	-15.66M
Operating Activities
Operating Cash Flow	210.70M	183.68M	40.07M	-10.97M	197.72M
Net Income	200.40M	94.42M	98.15M	51.02M	62.42M
Change in Accounts Payable	—	42.92M	3.15M	-49.76M	75.25M
Change in Accounts Receivable	—	-42.30M	-166.81M	-66.22M	-10.71M
Change in Inventory	—	-8.81M	-9.29M	-0.16M	-7.77M
Change in Other Net Operating Assets	—	-15.38M	32.62M	-20.19M	35.21M
Change in Working Capital	—	-23.57M	-140.33M	-136.33M	91.98M
Other Operating Activities	10.30M	25.38M	10.36M	14.93M	12.08M
Provision & Write-off of Bad Debts	—	4.41M	3.93M	-0.17M	1.22M
Depreciation & Amortization	—	81.73M	64.76M	56.94M	28.49M
Other Amortization	—	2.62M	3.53M	2.65M	1.46M
Cash Interest Paid	—	78.55M	24.02M	10.00M	1.14M
Loss (Gain) on Equity Investments	—	-1.19M	—	—	—
Asset Writedown & Restructuring Costs	—	—	—	14.59K	10.32K
Investing Activities
Investing Cash Flow	-646.90M	-262.23M	-454.39M	-310.04M	-315.49M
Capital Expenditures	—	-240.34M	-383.19M	-307.18M	-318.47M
Investment in Securities	—	—	—	—	3.28M
Other Investing Activities	-646.90M	—	—	—	—
Sale (Purchase) of Intangibles	—	-6.33M	-2.16M	-2.89M	-0.31M
Sale (Purchase) of Real Estate	—	-16.93M	-92.10M	—	—
Sale of Property, Plant & Equipment	—	1.36M	23.07M	0.03M	0.02M
Loss (Gain) From Sale of Assets	—	-110.05K	-328.45K	-27.50K	66.92K
Financing Activities
Financing Cash Flow	436.30M	100.92M	414.92M	278.13M	125.71M
Common Dividends Paid	—	-14.01M	—	—	-15.66M
Issuance of Common Stock	—	—	—	—	—
Long-Term Debt Issued	—	305.59M	622.91M	285.67M	148.91M
Long-Term Debt Repaid	—	-190.67M	-208.00M	-7.54M	-7.54M
Short-Term Debt Repaid	—	—	—	—	—
Total Debt Repaid	—	-190.67M	-208.00M	-7.54M	-7.54M
Net Debt Issued (Repaid)	—	114.92M	414.92M	278.13M	141.38M
Other Financing Activities	436.30M	—	—	—	—
Free Cash Flow & Returns
Free Cash Flow	210.70M	-56.66M	-343.12M	-318.15M	-120.76M
Free Cash Flow Margin	+14.9%	-4.7%	-35.0%	-39.0%	-17.2%
Free Cash Flow Per Share	4.73	-1.62	-9.80	-9.09	-1,207.55
Levered Free Cash Flow	0.81M	-112.73M	-369.73M	-359.89M	-122.63M
Unlevered Free Cash Flow	15.81M	-63.42M	-357.82M	-351.60M	-121.70M
Operating Cash Flow Growth	+14.7%	+358.4%	—	—	+31.9%
Net Cash Flow	0.10M	22.36M	0.60M	-42.88M	7.94M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	210.70M	183.68M	40.07M	-10.97M	197.72M
Free Cash Flow	210.70M	-56.66M	-343.12M	-318.15M	-120.76M
Capital Expenditures	—	-240.34M	-383.19M	-307.18M	-318.47M
Investing & Financing
Investing Cash Flow	-646.90M	-262.23M	-454.39M	-310.04M	-315.49M
Financing Cash Flow	436.30M	100.92M	414.92M	278.13M	125.71M
Dividends Paid	—	-14.01M	—	—	-15.66M
Operating Activities
Operating Cash Flow	210.70M	183.68M	40.07M	-10.97M	197.72M
Net Income	200.40M	94.42M	98.15M	51.02M	62.42M
Change in Accounts Payable	—	42.92M	3.15M	-49.76M	75.25M
Change in Accounts Receivable	—	-42.30M	-166.81M	-66.22M	-10.71M
Change in Inventory	—	-8.81M	-9.29M	-0.16M	-7.77M
Change in Other Net Operating Assets	—	-15.38M	32.62M	-20.19M	35.21M
Change in Working Capital	—	-23.57M	-140.33M	-136.33M	91.98M
Other Operating Activities	10.30M	25.38M	10.36M	14.93M	12.08M
Provision & Write-off of Bad Debts	—	4.41M	3.93M	-0.17M	1.22M
Depreciation & Amortization	—	81.73M	64.76M	56.94M	28.49M
Other Amortization	—	2.62M	3.53M	2.65M	1.46M
Cash Interest Paid	—	78.55M	24.02M	10.00M	1.14M
Loss (Gain) on Equity Investments	—	-1.19M	—	—	—
Asset Writedown & Restructuring Costs	—	—	—	14.59K	10.32K
Investing Activities
Investing Cash Flow	-646.90M	-262.23M	-454.39M	-310.04M	-315.49M
Capital Expenditures	—	-240.34M	-383.19M	-307.18M	-318.47M
Investment in Securities	—	—	—	—	3.28M
Other Investing Activities	-646.90M	—	—	—	—
Sale (Purchase) of Intangibles	—	-6.33M	-2.16M	-2.89M	-0.31M
Sale (Purchase) of Real Estate	—	-16.93M	-92.10M	—	—
Sale of Property, Plant & Equipment	—	1.36M	23.07M	0.03M	0.02M
Loss (Gain) From Sale of Assets	—	-110.05K	-328.45K	-27.50K	66.92K
Financing Activities
Financing Cash Flow	436.30M	100.92M	414.92M	278.13M	125.71M
Common Dividends Paid	—	-14.01M	—	—	-15.66M
Issuance of Common Stock	—	—	—	—	—
Long-Term Debt Issued	—	305.59M	622.91M	285.67M	148.91M
Long-Term Debt Repaid	—	-190.67M	-208.00M	-7.54M	-7.54M
Short-Term Debt Repaid	—	—	—	—	—
Total Debt Repaid	—	-190.67M	-208.00M	-7.54M	-7.54M
Net Debt Issued (Repaid)	—	114.92M	414.92M	278.13M	141.38M
Other Financing Activities	436.30M	—	—	—	—
Free Cash Flow & Returns
Free Cash Flow	210.70M	-56.66M	-343.12M	-318.15M	-120.76M
Free Cash Flow Margin	+14.9%	-4.7%	-35.0%	-39.0%	-17.2%
Free Cash Flow Per Share	4.73	-1.62	-9.80	-9.09	-1,207.55
Levered Free Cash Flow	0.81M	-112.73M	-369.73M	-359.89M	-122.63M
Unlevered Free Cash Flow	15.81M	-63.42M	-357.82M	-351.60M	-121.70M
Operating Cash Flow Growth	+14.7%	+358.4%	—	—	+31.9%
Net Cash Flow	0.10M	22.36M	0.60M	-42.88M	7.94M